Comparison of effectiveness of levocloperastine and dextrometorphan in treatment of dry cough
Phase 4
Completed
- Conditions
- Health Condition 1: J988- Other specified respiratory disorders
- Registration Number
- CTRI/2019/04/018787
- Lead Sponsor
- Arijit Ghosh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 43
Inclusion Criteria
1. Patients with dry cough will be included in the study
Exclusion Criteria
1. Age out of range,
2. Patients regularly using any anti-cough medications
3. Patients with comorbid respiratory, cardiovascular and psychiatric conditions
4. Coadministration of drugs that are likely to interact with levocloperastine or dextromethorphan
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in severity of cough.Timepoint: 14 days
- Secondary Outcome Measures
Name Time Method 1. The frequency of cough since last 24 h will be recorded on a 7-point Likert scale. <br/ ><br>2. The Quality of Life (QoL) will be assessed using 19-item patient-reported Leicester Cough Questionnaire (LCQ).Timepoint: 14 days